Cited by 206Mitochondrial Function and PathologyAdipose Tissue and MetabolismCardiovascular and exercise physiology

Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals

Open access
Phielix, E., Meex, R., Moonen-Kornips, E., Hesselink, M. K. C., Schrauwen, P.·2010·Diabetologia

Abstract

AIMS/HYPOTHESIS: We previously showed that type 2 diabetic patients are characterised by compromised intrinsic mitochondrial function. Here, we examined if exercise training could increase intrinsic mitochondrial function in diabetic patients compared with control individuals. METHODS: Fifteen male type 2 diabetic patients and 14 male control individuals matched for age, BMI and VO(2max) enrolled in a 12 week exercise intervention programme. Ex vivo mitochondrial function was assessed by high-resolution respirometry in permeabilised muscle fibres from vastus lateralis muscle. Before and after training, insulin-stimulated glucose disposal was examined during a hyperinsulinaemic-euglycaemic clamp. RESULTS: Diabetic patients had intrinsically lower ADP-stimulated state 3 respiration and lower carbonyl cyanide 4-(trifluoro-methoxy)phenylhydrazone (FCCP)-induced maximal oxidative respiration, both on glutamate and on glutamate and succinate, and in the presence of palmitoyl-carnitine (p < 0.05). After training, diabetic patients and control individuals showed increased state 3 respiration on the previously mentioned substrates (p < 0.05); however, an increase in FCCP-induced maximal oxidative respiration was observed only in diabetic patients (p < 0.05). The increase in mitochondrial respiration was accompanied by a 30% increase in mitochondrial content upon training (p < 0.01). After adjustment for mitochondrial density, state 3 and FCCP-induced maximal oxidative respiration were similar between groups after training. Improvements in mitochondrial respiration were paralleled by improvements in insulin-stimulated glucose disposal in diabetic patients, with a tendency for this in control individuals. CONCLUSIONS/INTERPRETATION: We confirmed lower intrinsic mitochondrial function in diabetic patients compared with control individuals. Diabetic patients increased their mitochondrial content to the same extent as control individuals and had similar intrinsic mitochondrial function, which occurred parallel with improved insulin sensitivity.

AI snapshot

Written from the paper’s full text.

TL;DR

In a 12-week supervised combined endurance and resistance training programme, men with type 2 diabetes and matched control individuals both increased skeletal muscle mitochondrial content and ex vivo mitochondrial respiration, with diabetic patients improving insulin-stimulated glucose disposal but not restoring it to control levels. The training-induced improvement in mitochondrial respiration was largely explained by increased mitochondrial density, and intrinsic mitochondrial function became similar between groups after training.

Key findings

  • Before training, diabetic patients had lower intrinsic mitochondrial function than controls: lower ADP-stimulated state 3 respiration on glutamate (MG3 17.2 ± 1.4 vs 22.5 ± 2.0 pmol mg−1 s−1, p < 0.05) and glutamate + succinate (MGS3 28.1 ± 2.0 vs 33.8 ± 2.0 pmol mg−1 s−1, p = 0.05), and lower FCCP-induced maximal respiration on glutamate + succinate (41.2 ± 2.8 vs 53.3 ± 3.1 pmol mg−1 s−1, p < 0.05) and with palmitoyl-carnitine (44.8 ± 3.1 vs 55.8 ± 3.1 pmol mg−1 s−1, p < 0.05); differences largely remained after normalisation to mtDNA copy number.
  • Training increased mitochondrial content by about 30%: mtDNA copy number rose from 2.0 ± 0.14 × 10⁶ to 2.7 ± 0.14 × 10⁶ AU in diabetic patients and from 1.8 ± 0.12 × 10⁶ to 2.7 ± 0.13 × 10⁶ AU in controls (both p < 0.01).
  • Training increased state 3 respiration in both groups (diabetic patients: MG3 +34%, MGS3 +33%, p < 0.01; controls: MG3 +26%, p < 0.05, MGS3 +28%, p < 0.01), but FCCP-induced maximal respiration increased only in diabetic patients (e.g. +33% on glutamate + succinate and +27% with palmitoyl-carnitine, p < 0.05). After adjustment for mitochondrial density, state 3 and FCCP-induced maximal respiration were similar between groups after training.
  • Insulin-stimulated glucose disposal (ΔRd) was lower in diabetic patients before training (8.1 ± 1.4 vs 16.0 ± 2.3 μmol kg−1 min−1, p < 0.01), increased in diabetic patients to 12.0 ± 1.9 μmol kg−1 min−1 (p < 0.05), showed a tendency to increase in controls (18.2 ± 2.5 μmol kg−1 min−1, p = 0.09), and remained lower in diabetic patients after training (p < 0.05). No correlations were found between ex vivo mitochondrial function and insulin-stimulated glucose disposal.

Methods

  • Fifteen male type 2 diabetic patients and 14 male normoglycaemic control individuals, matched for age, BMI and maximal aerobic capacity, completed a 12-week supervised combined endurance and resistance exercise training programme. Diabetic patients had well-controlled type 2 diabetes (HbA1c 7.1 ± 0.2%) and were on metformin only or metformin plus sulfonylurea.
  • Ex vivo mitochondrial function was measured by high-resolution respirometry in permeabilised vastus lateralis muscle fibres using multiple substrate combinations (glutamate, succinate, palmitoyl-carnitine, FCCP, oligomycin); mtDNA copy number was used as a marker of mitochondrial density. Insulin sensitivity was assessed with a 3 h hyperinsulinaemic–euglycaemic clamp combined with [6,6-²H₂]glucose infusion.
  • Data are means ± SE; between-group differences were tested with independent Student’s t tests, and within-group training effects with repeated-measures ANOVA; significance was set at p < 0.05.

Limitations

  • Stated: the study cannot determine whether the training-induced increase in mitochondrial content and oxidative function is responsible for improved insulin sensitivity; no correlation was found between changes in insulin sensitivity and mitochondrial function, suggesting they may be parallel rather than causally related.
  • Stated: substrate competition may differ between the ex vivo condition, where substrates were provided in excess, and the in vivo situation; it could not be deduced whether CPT1 or other substrate transporters are altered by training. The exact meaning of the finding that controls did not enhance FCCP-driven maximal respiratory capacity after training cannot be deduced from this study.
  • Evident from the text: the sample was small and included only men, limiting generalisability; one control individual was a non-responder for insulin sensitivity, and the figure legend reports 17 control individuals while the Methods report 14, indicating a possible inconsistency in reporting.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-010-1764-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

  • Findingown data

    Type 2 diabetic patients had similar intrinsic mitochondrial function compared with control individuals after training.

    “Diabetic patients increased their mitochondrial content to the same extent as control individuals and had similar intrinsic mitochondrial function, which occurred parallel with improved insulin sensitivity.”
    • Also stated in: § Discussion · plain
      “Importantly, type 2 diabetic patients had similar intrinsic mitochondrial function compared with control individuals, paralleled by an improvement, but not restoration, of insulin sensitivity.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • Findingown data

    Before training, mitochondrial density (mtDNA copy number) was not different between diabetic patients and control individuals.

    “Mitochondrial density measured as mtDNA copy number was not different between diabetic patients and control individuals before training (2.0 ± 0.14 × 106 vs 1.8 ± 0.12 × 106 AU).”
    Quote in the paperNot a substantial claim
  • Findingown data

    After training, mtDNA copy number was not significantly different between control individuals and diabetic patients.

    “After training, mtDNA copy number was not significantly different between control individuals and diabetic patients.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • Findingown data

    After training, state 4 respiration increased in diabetic patients.

    “Also, state 4 respiration and maximal respiratory capacity (FCCP-driven state u) levels increased by 28% (p < 0.01) and 33% (p < 0.01), respectively.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • Findingown data

    The insulin-stimulated change in R a (ΔR a) was significantly lower in type 2 diabetic patients compared with control individuals before training.

    “The insulin-stimulated change in R a (ΔR a) was significant lower in type 2 diabetic patients compared with control individuals (ΔR a 9.1 ± 1.3 vs 18.6 ± 2.8 μmol kg−1 min−1; p < 0.05).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 1-week discontinuation of glucose-lowering medication before testing is sufficient to eliminate medication effects on mitochondrial function and insulin sensitivity.
  • May combine two claims. 9
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim. 2
  • May combine two claims.

    Findingown data

    ΔR a increased upon exercise training in both diabetic patients and control individuals, but remained significantly lower in diabetic patients.

    “The ΔR a upon exercise training increased to 12.3 ± 1.5 (p < 0.05) in diabetic patients and to 21.2 ± 3.0 μmol kg−1 min−1 (p < 0.05) in control individuals, with ΔR a remaining significantly lower in diabetic patients compared with control individuals.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 1-week discontinuation of glucose-lowering medication before testing is sufficient to eliminate medication effects on mitochondrial function and insulin sensitivity.
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • May combine two claims.

    Findingown data

    After exercise training, insulin-mediated glucose disposal increased significantly in diabetic patients and tended to increase in control individuals.

    “and increased significantly after exercise training in diabetic patients to 12.0 ± 1.9 μmol kg−1 min−1 (p < 0.05) with a tendency for increase in control individuals (ΔR d 18.2 ± 2.5 μmol kg−1 min−1; p = 0.09).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The 1-week discontinuation of glucose-lowering medication before testing is sufficient to eliminate medication effects on mitochondrial function and insulin sensitivity.
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • May combine two claims.

    Findingown data

    Before training, type 2 diabetic patients had lower intrinsic ADP-stimulated state 3 respiration on glutamate and on glutamate plus succinate, and in the presence of palmitoyl-carnitine, compared with control individuals.

    “Diabetic patients had intrinsically lower ADP-stimulated state 3 respiration and lower carbonyl cyanide 4-(trifluoro-methoxy)phenylhydrazone (FCCP)-induced maximal oxidative respiration, both on glutamate and on glutamate and succinate, and in the presence of palmitoyl-carnitine (p < 0.05).”
    • Also stated in: § Ex vivo mitochondrial respirometry before training · plain
      “State 3 respiration on MG3 and on MGS3 was significantly lower in diabetic patients compared with control individuals (MG3: 17.2 ± 1.4 vs 22.5 ± 2.0 pmol mg−1 s−1, p < 0.05 and MGS3: 28.1 ± 2.0 vs 33.8 ± 2.0 pmol mg−1 s−1, p = 0.05).”
    • Also stated in: § Discussion · plain
      “In agreement with earlier results [5], we showed a ∼25% lower state 3 respiration and a ∼31% lower FCCP-induced maximal oxidative capacity in type 2 diabetic patients compared with control individuals, even when normalised to mitochondrial content.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In control individuals, MPG3 and MPGS3 increased upon training.

    “Similarly, upon the addition of palmitoyl-carnitine, MPG3 increased upon exercise training by 38% (p < 0.01), MPGS3 by 34% (p < 0.01) and O4 upon MPGS3 increased by 17% (p < 0.05).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • The quote only partly states this claim.

    Findingown data

    Exercise training increased mitochondrial content (mtDNA copy number) by about 30% in both diabetic patients and control individuals.

    “The increase in mitochondrial respiration was accompanied by a 30% increase in mitochondrial content upon training (p < 0.01).”
    • Also stated in: § Mitochondrial density · plain
      “After training, mtDNA copy number increased significantly to 2.7 ± 0.14 × 106 AU in diabetic patients (p < 0.01) and to 2.7 ± 0.13 × 106 AU (p < 0.01) in control individuals.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • May combine two claims.

    Findingown data

    After 12 weeks of exercise training, FCCP-induced maximal oxidative respiration increased in diabetic patients but not significantly in control individuals.

    “After training, diabetic patients and control individuals showed increased state 3 respiration on the previously mentioned substrates (p < 0.05); however, an increase in FCCP-induced maximal oxidative respiration was observed only in diabetic patients (p < 0.05).”
    • Also stated in: § Ex vivo mitochondrial respirometry: effect of training · plain
      “Also, state 4 respiration and maximal respiratory capacity (FCCP-driven state u) levels increased by 28% (p < 0.01) and 33% (p < 0.01), respectively.”
    • Also stated in: § Ex vivo mitochondrial respirometry: effect of training · plain
      “O4 respiration on MGS3 increased by 32% (p < 0.01) after training; however, FCCP-driven maximal respiratory capacity in the presence of glutamate and succinate was similar before and after training.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • May combine two claims.

    Findingown data

    Improvements in mitochondrial respiration were paralleled by improvements in insulin-stimulated glucose disposal in diabetic patients, with a tendency for this in control individuals.

    “Improvements in mitochondrial respiration were paralleled by improvements in insulin-stimulated glucose disposal in diabetic patients, with a tendency for this in control individuals.”
    • Also stated in: § Discussion · plain
      “These improvements were paralleled by improved insulin-stimulated glucose disposal in type 2 diabetic patients and control individuals.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The 1-week discontinuation of glucose-lowering medication before testing is sufficient to eliminate medication effects on mitochondrial function and insulin sensitivity.
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    All substrates were added in excess to ensure respiratory measurements were not limited by substrate availability.

    “All substrates were added in excess to ensure that respiratory measurements were not limited by substrate availability influencing oxygen flux.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    In diabetic patients, the training-induced increase in mitochondrial respiration was mainly accounted for by an increase in mitochondrial content; after normalization to mtDNA, the significant differences in respiration before and after training no longer persisted.

    “However, when respiration values were normalised to mtDNA copy number, significant differences reported for all states before and after training in diabetic patients no longer persisted (Fig. 2a,b), illustrating that the major part of the improvement in mitochondrial function was because of an increase in mitochondrial content.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • May combine two claims.

    Interpretationown data

    In control individuals, the training-induced increase in mitochondrial respiration was mainly accounted for by an increase in mitochondrial density; no significant increase in intrinsic mitochondrial respiration was observed after adjustment for mtDNA copy number.

    “Again, as in diabetic patients, the increase in mitochondrial respiration (with or without the addition of palmitoyl-carnitine) upon training was mainly accounted for by an increase in mitochondrial density, as no significant increase in intrinsic mitochondrial respiration was observed after adjustment for mtDNA copy number upon exercise training (Fig. 2a,b).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The final exercise bout was performed at least 2 days before the clamp.

    “The final exercise bout of the training programme was performed at least 2 days before the clamp.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    In control individuals only, exercise training did not enhance FCCP-driven maximal respiratory capacity, whereas it did in type 2 diabetic patients; as a result, FCCP-driven maximal respiratory capacity per mitochondrion was lower after training in controls.

    “Remarkably, in control individuals only, exercise training did not enhance FCCP-driven maximal respiratory capacity, as occurred in type 2 diabetic patients. As a result of the increase in mitochondrial content, FCCP-driven maximal respiratory capacity per mitochondrion was actually lower after training.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.
12 of 12
  • The paper relies on this without support.

    The 1-week discontinuation of glucose-lowering medication before testing is sufficient to eliminate medication effects on mitochondrial function and insulin sensitivity.

    “Glucose-lowering medication was continued throughout the study except for the week preceding the actual tests and sampling of the biopsy.”
    “Diabetic patients discontinued their glucose-lowering medication 1 week prior to the clamp, but restarted the use of medication after the test days.”
  • The paper relies on this without support.

    The final exercise bout at least 2 days before the clamp is sufficient to avoid acute exercise effects on mitochondrial function and insulin sensitivity.

    “The final exercise bout of the training programme was performed at least 2 days before the clamp.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In humans, physical exercise increases total mitochondrial mass and uncoupling in skeletal muscular cells.

    “In humans, physical exercise increases total mitochondrial mass and uncoupling in skeletal muscular cells [192].”
  • In patients with type 2 diabetes, walking and ergometer cycling increase mitochondrial muscle respiration, mitochondrial content and density, and oxidative enzyme activity.

    “In patients with T2DM, walking and ergometer cycling exercise increased mitochondrial muscle respiration and mitochondrial content and density, as well as the activity of oxidative enzymes214,215.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Figure 1 lists more controls than were enrolled

    Minor

    The paper says 14 control individuals were included, but the Figure 1 caption says it shows 17 control individuals.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Phielix, E., Meex, R., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P.
Affiliations
Maastricht University Medical Centre (NL)
Corresponding author
Schrauwen, P.
Venue
Diabetologia
Published
2010-04-27
Volume
53
Issue
8
Pages
1714-1721
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1966012125
Cited by
206
References
22
Citations by year
2026: 5 · 2025: 9 · 2024: 16 · 2023: 23 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 6 · 2018: 8 · 2017: 23 · 2016: 12 · 2015: 10 · 2014: 11 · 2013: 12 · 2012: 14
FWCI
5.60
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
Diabetes Fonds (2004.00.059)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
type 2 diabetes, exercise training, mitochondrial function, mitochondrial content, skeletal muscle, vastus lateralis, insulin-stimulated glucose disposal, insulin sensitivity, oxidative respiration, state 3 respiration, palmitoylcarnitine, mitochondrial density
MeSH terms
Analysis of Variance, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Mitochondria, Oxygen Consumption, Glucose Clamp Technique, Exercise, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review